Transcat, Inc. (TRNS) Director John T. Smith Sells 2,000 Shares

Transcat, Inc. (NASDAQ:TRNS) Director John T. Smith sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $15.70, for a total transaction of $31,400.00. Following the sale, the director now directly owns 33,100 shares in the company, valued at approximately $519,670. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Shares of Transcat, Inc. (NASDAQ TRNS) opened at $15.25 on Thursday. The firm has a market cap of $110.15, a P/E ratio of 24.06, a price-to-earnings-growth ratio of 2.92 and a beta of 0.40. Transcat, Inc. has a 12-month low of $11.02 and a 12-month high of $16.49. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.53 and a current ratio of 1.98.

Several analysts have weighed in on the stock. Zacks Investment Research raised shares of Transcat from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research report on Saturday, February 3rd. Singular Research boosted their target price on shares of Transcat from $15.30 to $20.00 and gave the stock a “buy” rating in a research report on Monday.

A number of large investors have recently added to or reduced their stakes in the business. Northern Trust Corp grew its position in Transcat by 9.5% during the 2nd quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock worth $220,000 after purchasing an additional 1,570 shares during the last quarter. Vanguard Group Inc. grew its position in Transcat by 3.4% during the 2nd quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock worth $1,623,000 after purchasing an additional 4,450 shares during the last quarter. QCI Asset Management Inc. NY grew its position in Transcat by 31.1% during the 3rd quarter. QCI Asset Management Inc. NY now owns 32,234 shares of the scientific and technical instruments company’s stock worth $437,000 after purchasing an additional 7,647 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Transcat by 3.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 290,146 shares of the scientific and technical instruments company’s stock worth $3,960,000 after purchasing an additional 8,771 shares during the last quarter. Finally, Wedge Capital Management L L P NC purchased a new stake in Transcat during the 4th quarter worth approximately $378,000. 56.53% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: This story was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://sportsperspectives.com/2018/02/08/transcat-inc-trns-director-john-t-smith-sells-2000-shares.html.

Transcat Company Profile

Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).

Insider Buying and Selling by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply